Although the contribution of IL-2 signaling in colitis is unclear, the increased IL-2 signaling due to diminished BLIMP1 potentially provides an additional explanation for the aggravated inflammation during colitis in addition to the effects of lower levels of IL-10 and CTLA-4 (60–63). Here, PRDM1 is linked to colitis.